Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Thoracic Cancer|June 8, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung CancerGen Lin, Yongsheng Wang, Tao Xin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2023
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancerYiquan Xu, Jingjing Yan, Chengzhi Zhou, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2026
Development and validation of a risk-stratification model for individualized management of leptomeningeal metastases in EGFR- mutant NSCLC (LM-Index)Yingxi Wu, Haiyang Chen, Yufeng Wu, et al.
Frontiers in Immunology|November 28, 2022
CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer typesXinlong Zheng, Kan Jiang, Weijin Xiao, et al.
Medcomm|March 11, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response scoreXinlong Zheng, Tao Lu, Shiwen Wu, et al.
Frontiers in Immunology|August 29, 2022
Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinomaChao Li, Xiaobin Zheng, Pansong Li, et al.
BMC Cancer|December 16, 2023
Baseline C-reactive protein predicts efficacy of the first-line immune checkpoint inhibitors plus chemotherapy in advanced lung squamous cell carcinoma: a retrospective, multicenter studyXinlong Zheng, Longfeng Zhang, Lin Wu, et al.
Therapeutic Advances in Medical Oncology|August 7, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysisQiaofeng Zhong, Longfeng Zhang, Lin Wu, et al.
Thoracic Cancer|November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancerDingzhi Huang, Gen Lin, Qian Chu, et al.
Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.
Pageof 5